Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin

To assess the efficacy of Sn-mesoporphyrin (SnMP), a potent inhibitor of bilirubin production, in: a) moderating the need for phototherapy (PT) in full-term breastfed infants with plasma bilirubin concentrations (PBC) of >/=256.5 micromol/L and /=15 mg/dL and /=48 and

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 1999-01, Vol.103 (1), p.1-5
Hauptverfasser:	Martinez, Jorge C, Garcia, Horacio O, Otheguy, Lydia E, Drummond, George S, Kappas, Attallah
Format:	Artikel
Sprache:	eng
Schlagworte:	Babies Bilirubin - blood Biological and medical sciences Breast Feeding Care and treatment Digestive system Drug therapy Enzyme Inhibitors - therapeutic use Female Heme Oxygenase (Decyclizing) - antagonists & inhibitors Humans Hyperbilirubinemia Hyperbilirubinemia - blood Hyperbilirubinemia - drug therapy Infant, Newborn Injections, Intramuscular Male Medical disorders Medical sciences Metalloporphyrins - therapeutic use Pediatrics Pharmacology. Drug treatments Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To assess the efficacy of Sn-mesoporphyrin (SnMP), a potent inhibitor of bilirubin production, in: a) moderating the need for phototherapy (PT) in full-term breastfed infants with plasma bilirubin concentrations (PBC) of >/=256.5 micromol/L and /=15 mg/dL and /=48 and
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.103.1.1